{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:03:41Z","timestamp":1781103821479,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771971 and 31170648"],"award-info":[{"award-number":["31771971 and 31170648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute liver failure is divided into hyperacute, acute and subacute liver failure. Ascites is a common complication of subacute liver failure. Although animal models of acute liver failure have been established, the study of the pathogenesis of subacute liver failure with ascites complication is hampered by the lack of experimental animal model. The present study aimed at providing a mouse model of subacute liver failure with ascites complication. Kunming mice were intraperitoneally injected with (-)-epigallocatechin-3-gallate (EGCG), a redox-active polyphenol from green tea, for 32 consecutive days with step-wise increased dosage. The EGCG treatment resulted in liver failure as evidenced by extensive hepatocyte necrosis observed histologically along with significant elevation of serum alanine aminotransferase, aspartate aminotransferase, total bilirubin and direct bilirubin levels as well as significant reduction of serum albumin. Liver fibrosis was not observed by Masson staining and fibrosis-associated proteins were not increased. The mortality was less than 12% and the survival mice developed noticeable ascites. Hepatic thioredoxin and glutathione systems were activated by the EGCG. These adaptive responses might render most mice tolerable to the EGCG treatment. The EGCG treatment significantly up-regulated renal urea transporter A1 and promoted its trafficking to apical membrane. These alterations, known to increase water reabsorption, may be responsible, at least in part, for the formation of the ascites. Overall, the mice treated with gradually elevated doses of EGCG exhibits some of the features observed in patients with subacute liver failure, especially ascites. This mouse model is a useful tool for investigating the pathogenesis of subacute liver failure with ascites complication.<\/jats:p>","DOI":"10.1038\/s41598-019-54691-0","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T11:37:14Z","timestamp":1575286634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate"],"prefix":"10.1038","volume":"9","author":[{"given":"Xiaoxiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung S.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"54691_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","volume":"376","author":"W Bernal","year":"2010","unstructured":"Bernal, W., Auzinger, G., Dhawan, A. & Wendon, J. Acute liver failure. Lancet 376, 190\u2013201 (2010).","journal-title":"Lancet"},{"key":"54691_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1440-1746.1999.01905.x","volume":"14","author":"BN Tandon","year":"1999","unstructured":"Tandon, B. N. et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol 14, 403\u2013404 (1999).","journal-title":"J Gastroenterol Hepatol"},{"key":"54691_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1046\/j.1440-1746.2000.02073.x","volume":"15","author":"SK Acharya","year":"2000","unstructured":"Acharya, S. K., Panda, S. K., Saxena, A. & Gupta, S. D. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol 15, 473\u2013479 (2000).","journal-title":"J Gastroenterol Hepatol"},{"key":"54691_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-2008-1040593","volume":"6","author":"J Bernuau","year":"1986","unstructured":"Bernuau, J., Rueff, B. & Benhamou, J. P. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6, 97\u2013106 (1986).","journal-title":"Semin Liver Dis"},{"key":"54691_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.5694\/j.1326-5377.1991.tb121308.x","volume":"154","author":"AG Sheil","year":"1991","unstructured":"Sheil, A. G. et al. Acute and subacute fulminant hepatic failure: the role of liver transplantation. Med J Aust 154, 724\u2013728 (1991).","journal-title":"Med J Aust"},{"key":"54691_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/hep.1840060222","volume":"6","author":"AE Gimson","year":"1986","unstructured":"Gimson, A. E., O\u2019Grady, J., Ede, R. J., Portmann, B. & Williams, R. Late onset hepatic failure: clinical, serological and histological features. Hepatology 6, 288\u2013294 (1986).","journal-title":"Hepatology"},{"key":"54691_CR7","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.jhep.2014.12.016","volume":"62","author":"W Bernal","year":"2015","unstructured":"Bernal, W., Lee, W. M., Wendon, J., Larsen, F. S. & Williams, R. Acute liver failure: A curable disease by 2024? J Hepatol 62, S112\u2013120 (2015).","journal-title":"J Hepatol"},{"key":"54691_CR8","first-page":"482","volume":"90","author":"WP He","year":"2010","unstructured":"He, W. P., Liu, X. Y., Hu, J. H. & Wang, H. F. Clinical features and prognostic analysis of 51 drug-induced case of liver failure. Zhonghua Yi Xue Za Zhi 90, 482\u2013485 (2010).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"54691_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1023\/A:1018876328561","volume":"43","author":"RK Dhiman","year":"1998","unstructured":"Dhiman, R. K., Seth, A. K., Jain, S., Chawla, Y. K. & Dilawari, J. B. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 43, 1311\u20131316 (1998).","journal-title":"Dig Dis Sci"},{"key":"54691_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0168-8278(95)80193-6","volume":"23","author":"AJ Ellis","year":"1995","unstructured":"Ellis, A. J. et al. Late-onset hepatic failure: clinical features, serology and outcome following transplantation. J Hepatol 23, 363\u2013372 (1995).","journal-title":"J Hepatol"},{"key":"54691_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1872-034X.2012.01105.x","volume":"43","author":"M Oketani","year":"2013","unstructured":"Oketani, M. et al. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009. Hepatol Res 43, 97\u2013105 (2013).","journal-title":"Hepatol Res"},{"key":"54691_CR12","first-page":"21","volume":"6","author":"PN Newsome","year":"2000","unstructured":"Newsome, P. N., Plevris, J. N., Nelson, L. J. & Hayes, P. C. Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl 6, 21\u201331 (2000).","journal-title":"Liver Transpl"},{"key":"54691_CR13","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.3748\/wjg.15.3086","volume":"15","author":"MJ Tunon","year":"2009","unstructured":"Tunon, M. J., Alvarez, M., Culebras, J. M. & Gonzalez-Gallego, J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol 15, 3086\u20133098 (2009).","journal-title":"World J Gastroenterol"},{"key":"54691_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep31703","volume":"6","author":"M Han","year":"2016","unstructured":"Han, M. et al. Safety and anti-hyperglycemic efficacy of various tea types in mice. Sci Rep 6, 31703 (2016).","journal-title":"Sci Rep"},{"key":"54691_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1146\/annurev-nutr-071811-150717","volume":"33","author":"CS Yang","year":"2013","unstructured":"Yang, C. S. & Hong, J. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr 33, 161\u2013181 (2013).","journal-title":"Annu Rev Nutr"},{"key":"54691_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/mnfr.201500428","volume":"60","author":"CS Yang","year":"2016","unstructured":"Yang, C. S., Zhang, J., Zhang, L., Huang, J. & Wang, Y. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res 60, 160\u2013174 (2016).","journal-title":"Mol Nutr Food Res"},{"key":"54691_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7326\/0003-4819-143-7-200510040-00010","volume":"143","author":"Q Amir","year":"2005","unstructured":"Amir, Q. et al. Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine 143, 517\u2013521 (2005).","journal-title":"Annals of Internal Medicine"},{"key":"54691_CR18","doi-asserted-by":"crossref","unstructured":"Javaid, A. & Bonkovsky, H. L. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern. J Hepatol 45, 334\u2013335; author reply 335\u2013336, (2006).","DOI":"10.1016\/j.jhep.2006.05.005"},{"key":"54691_CR19","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00204-015-1521-x","volume":"89","author":"G Mazzanti","year":"2015","unstructured":"Mazzanti, G., Di Sotto, A. & Vitalone, A. Hepatotoxicity of green tea: an update. Arch Toxicol 89, 1175\u20131191 (2015).","journal-title":"Arch Toxicol"},{"key":"54691_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.28813","volume":"65","author":"VJ Navarro","year":"2017","unstructured":"Navarro, V. J. et al. Liver injury from herbal and dietary supplements. Hepatology 65, 363\u2013373 (2017).","journal-title":"Hepatology"},{"key":"54691_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00228-008-0610-7","volume":"65","author":"G Mazzanti","year":"2009","unstructured":"Mazzanti, G. et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 65, 331\u2013341 (2009).","journal-title":"Eur J Clin Pharmacol"},{"key":"54691_CR22","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/lt.21021","volume":"12","author":"M Molinari","year":"2006","unstructured":"Molinari, M. et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl 12, 1892\u20131895 (2006).","journal-title":"Liver Transpl"},{"key":"54691_CR23","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.3748\/wjg.v19.i31.5174","volume":"19","author":"SS Patel","year":"2013","unstructured":"Patel, S. S., Beer, S., Kearney, D. L., Phillips, G. & Carter, B. A. Green tea extract: a potential cause of acute liver failure. World J Gastroenterol 19, 5174\u20135177 (2013).","journal-title":"World J Gastroenterol"},{"key":"54691_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5694\/mja15.00816","volume":"204","author":"RJ Smith","year":"2016","unstructured":"Smith, R. J., Bertilone, C. & Robertson, A. G. Fulminant liver failure and transplantation after use of dietary supplements. Med J Aust 204, 30\u201332 (2016).","journal-title":"Med J Aust"},{"key":"54691_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.toxlet.2017.06.008","volume":"277","author":"W Dekant","year":"2017","unstructured":"Dekant, W., Fujii, K., Shibata, E., Morita, O. & Shimotoyodome, A. Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements. Toxicol Lett 277, 104\u2013108 (2017).","journal-title":"Toxicol Lett"},{"key":"54691_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","volume":"95","author":"J Hu","year":"2018","unstructured":"Hu, J., Webster, D., Cao, J. & Shao, A. The safety of green tea and green tea extract consumption in adults - Results of a systematic review. Regul Toxicol Pharmacol 95, 412\u2013433 (2018).","journal-title":"Regul Toxicol Pharmacol"},{"key":"54691_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.taap.2014.12.018","volume":"283","author":"D Wang","year":"2015","unstructured":"Wang, D., Wang, Y., Wan, X., Yang, C. S. & Zhang, J. Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway. Toxicol Appl Pharmacol 283, 65\u201374 (2015).","journal-title":"Toxicol Appl Pharmacol"},{"key":"54691_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2017.09.027","volume":"113","author":"K Zhang","year":"2017","unstructured":"Zhang, K. et al. Synergistic toxicity of epigallocatechin-3-gallate and diethyldithiocarbamate, a lethal encounter involving redox-active copper. Free Radic Biol Med 113, 143\u2013156 (2017).","journal-title":"Free Radic Biol Med"},{"key":"54691_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/jpi.12281","volume":"59","author":"D Wang","year":"2015","unstructured":"Wang, D. et al. Melatonin attenuates (-)-epigallocatehin-3-gallate-triggered hepatotoxicity without compromising its downregulation of hepatic gluconeogenic and lipogenic genes in mice. J Pineal Res 59, 497\u2013507 (2015).","journal-title":"J Pineal Res"},{"key":"54691_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.dld.2011.10.014","volume":"44","author":"F Corradi","year":"2012","unstructured":"Corradi, F. et al. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites. Dig Liver Dis 44, 239\u2013244 (2012).","journal-title":"Dig Liver Dis"},{"key":"54691_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jhep.2005.01.034","volume":"43","author":"M Domenicali","year":"2005","unstructured":"Domenicali, M. et al. A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. J Hepatol 43, 92\u201397 (2005).","journal-title":"J Hepatol"},{"key":"54691_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.21699","volume":"46","author":"D Ackermann","year":"2007","unstructured":"Ackermann, D. et al. Sodium retention and ascites formation in a cholestatic mice model: role of aldosterone and mineralocorticoid receptor? Hepatology 46, 173\u2013179 (2007).","journal-title":"Hepatology"},{"key":"54691_CR33","doi-asserted-by":"publisher","first-page":"R625","DOI":"10.1152\/ajpregu.00418.2005","volume":"292","author":"HC Thiesson","year":"2007","unstructured":"Thiesson, H. C. et al. Renal sodium retention in cirrhotic rats depends on glucocorticoid-mediated activation of mineralocorticoid receptor due to decreased renal 11beta-HSD-2 activity. Am J Physiol Regul Integr Comp Physiol 292, R625\u2013636 (2007).","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"54691_CR34","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/gut.52.8.1194","volume":"52","author":"P Ivarsen","year":"2003","unstructured":"Ivarsen, P. et al. Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis. Gut 52, 1194\u20131199 (2003).","journal-title":"Gut"},{"key":"54691_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.1840210128","volume":"21","author":"Y Asahina","year":"1995","unstructured":"Asahina, Y. et al. Increased gene expression of water channel in cirrhotic rat kidneys. Hepatology 21, 169\u2013173 (1995).","journal-title":"Hepatology"},{"key":"54691_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1046\/j.1523-1755.2000.00156.x","volume":"58","author":"P Fernandez-Llama","year":"2000","unstructured":"Fernandez-Llama, P. et al. Dysregulation of renal aquaporins and Na-Cl cotransporter in CCl4-induced cirrhosis. Kidney Int 58, 216\u2013228 (2000).","journal-title":"Kidney Int"},{"key":"54691_CR37","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1681\/ASN.2006030246","volume":"17","author":"JD Klein","year":"2006","unstructured":"Klein, J. D. et al. Vasopressin increases plasma membrane accumulation of urea transporter UT-A1 in rat inner medullary collecting ducts. J Am Soc Nephrol 17, 2680\u20132686 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"54691_CR38","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/ki.2013.62","volume":"83","author":"F Li","year":"2013","unstructured":"Li, F. et al. A novel small-molecule thienoquinolin urea transporter inhibitor acts as a potential diuretic. Kidney Int 83, 1076\u20131086 (2013).","journal-title":"Kidney Int"},{"key":"54691_CR39","doi-asserted-by":"publisher","first-page":"F1363","DOI":"10.1152\/ajprenal.00421.2014","volume":"307","author":"H Ren","year":"2014","unstructured":"Ren, H. et al. Thienoquinolins exert diuresis by strongly inhibiting UT-A urea transporters. Am J Physiol Renal Physiol 307, F1363\u20131372 (2014).","journal-title":"Am J Physiol Renal Physiol"},{"key":"54691_CR40","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2013.08.005","volume":"20","author":"C Esteva-Font","year":"2013","unstructured":"Esteva-Font, C., Phuan, P. W., Anderson, M. O. & Verkman, A. S. A small molecule screen identifies selective inhibitors of urea transporter UT-A. Chem Biol 20, 1235\u20131244 (2013).","journal-title":"Chem Biol"},{"key":"54691_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/anie.201000044","volume":"50","author":"S Quideau","year":"2011","unstructured":"Quideau, S., Deffieux, D., Douat-Casassus, C. & Pouysegu, L. Plant polyphenols: chemical properties, biological activities, and synthesis. Angew Chem Int Ed Engl 50, 586\u2013621 (2011).","journal-title":"Angew Chem Int Ed Engl"},{"key":"54691_CR42","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/bph.13630","volume":"174","author":"A Smeriglio","year":"2017","unstructured":"Smeriglio, A., Barreca, D., Bellocco, E. & Trombetta, D. Proanthocyanidins and hydrolysable tannins: occurrence, dietary intake and pharmacological effects. Br J Pharmacol 174, 1244\u20131262 (2017).","journal-title":"Br J Pharmacol"},{"key":"54691_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-3835(00)00477-8","volume":"157","author":"LL Yang","year":"2000","unstructured":"Yang, L. L., Lee, C. Y. & Yen, K. Y. Induction of apoptosis by hydrolyzable tannins from Eugenia jambos L. on human leukemia cells. Cancer Lett 157, 65\u201375 (2000).","journal-title":"Cancer Lett"},{"key":"54691_CR44","unstructured":"Korpassy, B. & Kovacs, K. Experimental liver cirrhosis in rats produced by prolonged subcutaneous administration of solutions of tannic acid. Br J Exp Pathol, 30, 266\u2013272, 262 pl, (1949)."},{"key":"54691_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.redox.2016.10.009","volume":"10","author":"R Dong","year":"2016","unstructured":"Dong, R. et al. Epigallocatechin-3-gallate enhances key enzymatic activities of hepatic thioredoxin and glutathione systems in selenium-optimal mice but activates hepatic Nrf2 responses in selenium-deficient mice. Redox Biol 10, 221\u2013232 (2016).","journal-title":"Redox Biol"},{"key":"54691_CR46","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ajcn\/80.3.742","volume":"80","author":"JH Chen","year":"2004","unstructured":"Chen, J. H. et al. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr 80, 742\u2013751 (2004).","journal-title":"Am J Clin Nutr"},{"key":"54691_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tox.2010.04.014","volume":"273","author":"GL Tipoe","year":"2010","unstructured":"Tipoe, G. L. et al. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology 273, 45\u201352 (2010).","journal-title":"Toxicology"},{"key":"54691_CR48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.fct.2009.10.030","volume":"48","author":"JD Lambert","year":"2010","unstructured":"Lambert, J. D. et al. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol 48, 409\u2013416 (2010).","journal-title":"Food Chem Toxicol"},{"key":"54691_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.fct.2014.12.009","volume":"76","author":"KD James","year":"2015","unstructured":"James, K. D., Forester, S. C. & Lambert, J. D. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate. Food Chem Toxicol 76, 103\u2013108 (2015).","journal-title":"Food Chem Toxicol"},{"key":"54691_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0076-6879(02)47012-7","volume":"347","author":"AD Smith","year":"2002","unstructured":"Smith, A. D. & Levander, O. A. High-throughput 96-well microplate assays for determining specific activities of glutathione peroxidase and thioredoxin reductase. Methods Enzymol 347, 113\u2013121 (2002).","journal-title":"Methods Enzymol"},{"key":"54691_CR51","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.bbagen.2014.02.028","volume":"1840","author":"K Sun","year":"2014","unstructured":"Sun, K. et al. Serum thioredoxin reductase levels increase in response to chemically induced acute liver injury. Biochim Biophys Acta 1840, 2105\u20132111 (2014).","journal-title":"Biochim Biophys Acta"},{"key":"54691_CR52","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","volume":"113","author":"I Carlberg","year":"1985","unstructured":"Carlberg, I. & Mannervik, B. Glutathione reductase. Methods Enzymol 113, 484\u2013490 (1985).","journal-title":"Methods Enzymol"},{"key":"54691_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.abb.2015.08.005","volume":"583","author":"M Scian","year":"2015","unstructured":"Scian, M. & Atkins, W. M. The busulfan metabolite EdAG irreversibly glutathionylates glutaredoxins. Arch Biochem Biophys 583, 96\u2013104 (2015).","journal-title":"Arch Biochem Biophys"},{"key":"54691_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2018.07.017","volume":"126","author":"G Zhao","year":"2018","unstructured":"Zhao, G. et al. Selenium nanoparticles are more efficient than sodium selenite in producing reactive oxygen species and hyper-accumulation of selenium nanoparticles in cancer cells generates potent therapeutic effects. Free Radic Biol Med 126, 55\u201366 (2018).","journal-title":"Free Radic Biol Med"},{"key":"54691_CR55","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.phrs.2008.03.013","volume":"57","author":"S Tiwari","year":"2008","unstructured":"Tiwari, S., Blasi, E. R., Heyen, J. R., McHarg, A. D. & Ecelbarger, C. M. Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats. Pharmacol Res 57, 383\u2013392 (2008).","journal-title":"Pharmacol Res"},{"key":"54691_CR56","doi-asserted-by":"publisher","first-page":"F178","DOI":"10.1152\/ajprenal.00447.2006","volume":"293","author":"S Tiwari","year":"2007","unstructured":"Tiwari, S., Nordquist, L., Halagappa, V. K. & Ecelbarger, C. A. Trafficking of ENaC subunits in response to acute insulin in mouse kidney. Am J Physiol Renal Physiol 293, F178\u2013185 (2007).","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54691-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:51:03Z","timestamp":1671295863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54691-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54691"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54691-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"19 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18102"}}